We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Securities and Exchange Commission (SEC) Tuesday levied a $20.8 million fine against biopharmaceutical company Clovis Oncology and two company executives for concealing the true efficacy rate of its lung cancer drug Roci (rociletinib). Read More
California’s Department of Insurance filed suit against AbbVie Tuesday alleging the company increased Humira prescriptions through kickbacks and paid nurses to push patients to refill prescriptions. Read More
The FDA Wednesday issued guidance on labeling and safety testing for heparin-containing combination products, finalizing the agency’s 2015 draft. Read More
The FDA released a trio of guidances Wednesday on Drug Supply Chain and Security Act (DSCSA) requirements for drugmakers to attach identifiers to their prescription drugs. Read More
The Senate passed legislation Monday that would bar PBMs or insurers from including gag clauses in their contracts with pharmacies, sending the bill to the House by a vote of 98-2. Read More
Lawmakers are hoping to quickly reconcile the Senate’s newly-passed Opioid Crisis Response Act (S. 2680) with the package the House passed as soon as Friday and vote through a final bill next week. Read More
The FDA Tuesday added immediate-release opioids to its risk evaluation and mitigation strategy (REMS) for opioid analgesics, saying the move will encourage “rational prescribing.” Read More